Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood FlowCaroline J. Breitbach, John C. Bell, Harold Atkins et al.|Molecular Therapy|2007Cited by 277
Targeting Tumor Vasculature With an Oncolytic VirusCaroline J. Breitbach, John C. Bell, Naomi S. De Silva et al.|Molecular Therapy|2011Cited by 202
Synergistic Interaction Between Oncolytic Viruses Augments Tumor KillingJohn C. Bell, Jean‐Simon Diallo, J. Andrea McCart et al.|Molecular Therapy|2010Cited by 132
Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell VaccineChantal G. Lemay, Rebecca C. Auer, Julia L. Rintoul et al.|Molecular Therapy|2012Cited by 93
Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus MacaquesLaura Evgin, J. Andrea McCart, Sergio A. Acuña et al.|Molecular Therapy|2015Cited by 80